Abstract
Purpose: The purpose of our study is to retrospectively review our institutional experience with adult rhabdomyosarcoma (RMS) to determine presentation, prognostic factors and patterns of failure in this disease.
Materials and Methods: All patients ≥ 16 years with a diagnosis of rhabdomyosarcoma were retrospectively reviewed. Tumors were classified according to the Intergroup Rhabdomyosarcoma Study (IRS) staging and grouping system. Median follow-up for surviving patients was 12.5 years.
Results: A total of 39 patients (23 male, 16 female) were seen at our institution from 1961 to 1999. Median age was 45 years, and age distribution showed a bimodal peak at the late teens to twenties and later in the sixties. Tumor in the extremity was most common as seen in 15 (39%); this was followed by head and neck in 11 (28%), genitourinary in eight (20%), trunk/retroperitoneum in four (10%) and other in one (3%). Tumor stage was T1 in 21 (52%) while 26 (67%) were > 5 cm in size. Pleomorphic histology was most common (36%) and increased in incidence according to age category: 0% for ages 16–19, 27% for ages 20–49 and 60% for ages ≥ 50 years old (P < 0.01). The median survival for the entire population was 2.25 years with a 5-year overall survival rate of 35%. Multivariate analysis identified early IRS stage (P < 0.001), non-embryonal histology (P < 0.009), favorable site (P = 0.024), female gender (P = 0.034), early T-stage (P = 0.034) and absence of nodal metastases (P = 0.037) as predictors of a better survival. The 5-year progression-free survival rate was 21%. Female gender (P = 0.002), non-embryonal histology (P = 0.009), early IRS stage (P = 0.02) and early T stage (P = 0.033) were found on multivariate analysis to predict for improved progression-free survival. The 5-year local control rate was 51%, and multivariate analysis found that only early T-stage was predictive of better local control (P = 0.045). Five of six Group II patients and five of eight Group III patients who received radiotherapy (RT) were locally controlled. Only one of five Group III patients was locally controlled without RT.
Conclusions: The overall prognosis of adult RMS is worse than reported in children, but age criteria within the adult population did not further classify outcome. RT is an effective local modality providing local control in almost all Group II and majority of Group III patients.
Full Text
The Full Text of this article is available as a PDF (121.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crist W. M., Anderson J. R., Meza J. L., Fryer C., Raney R. B., Ruymann F. B., Breneman J., Qualman S. J., Wiener E., Wharam M. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001 Jun 15;19(12):3091–3102. doi: 10.1200/JCO.2001.19.12.3091. [DOI] [PubMed] [Google Scholar]
- Czyzewski E. A., Goldman S., Mundt A. J., Nachman J., Rubin C., Hallahan D. E. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):569–577. doi: 10.1016/s0360-3016(99)00063-2. [DOI] [PubMed] [Google Scholar]
- Esnaola N. F., Rubin B. P., Baldini E. H., Vasudevan N., Demetri G. D., Fletcher C. D., Singer S. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg. 2001 Aug;234(2):215–223. doi: 10.1097/00000658-200108000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaffney E. F., Dervan P. A., Fletcher C. D. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 1993 Jun;17(6):601–609. [PubMed] [Google Scholar]
- Hawkins W. G., Hoos A., Antonescu C. R., Urist M. J., Leung D. H., Gold J. S., Woodruff J. M., Lewis J. J., Brennan M. F. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 2001 Feb 15;91(4):794–803. [PubMed] [Google Scholar]
- Prestidge B. R., Donaldson S. S. Treatment results among adults with childhood tumors: a 20-year experience. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):507–514. doi: 10.1016/0360-3016(89)90101-6. [DOI] [PubMed] [Google Scholar]
- Tallini G., Parham D. M., Dias P., Cordon-Cardo C., Houghton P. J., Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol. 1994 Apr;144(4):693–701. [PMC free article] [PubMed] [Google Scholar]
- Wesche W. A., Fletcher C. D., Dias P., Houghton P. J., Parham D. M. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol. 1995 Mar;19(3):261–269. doi: 10.1097/00000478-199503000-00003. [DOI] [PubMed] [Google Scholar]
- Wolden S. L., Anderson J. R., Crist W. M., Breneman J. C., Wharam M. D., Jr, Wiener E. S., Qualman S. J., Donaldson S. S. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol. 1999 Nov;17(11):3468–3475. doi: 10.1200/JCO.1999.17.11.3468. [DOI] [PubMed] [Google Scholar]